Summary of Significant Accounting Policies - Schedule of Deferred Tax Assets (Details) - PHOENIX BIOTECH ACQUISITION CORP. [Member] - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies - Schedule of Deferred Tax Assets (Details) [Line Items]
General and administration expenses before business combination	$ 607,516	$ 596,692
Valuation allowance for deferred tax assets	(607,516)	(596,692)
Total

Deferred tax expenses capitalized expenses before business combination.

No definition available.

Name:	cero_DeferredTaxExpensesCapitalizedExpensesBeforeBusinessCombination
Namespace Prefix:	cero_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- References

No definition available.

+ Details

Name:	cero_SummaryofSignificantAccountingPoliciesScheduleofDeferredTaxAssetsDetailsLineItems
Namespace Prefix:	cero_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-2

+ Details

Name:	us-gaap_DeferredTaxAssetsLiabilitiesNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-2

+ Details

Name:	us-gaap_DeferredTaxAssetsValuationAllowance
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	srt_ConsolidatedEntitiesAxis=cero_PHOENIXBIOTECHACQUISITIONCORPMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: